Position in ATAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Derivatives in ATAI
reported options exposure · as of Mar 31, 2026CallValue
$297,006
CallShares
83,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOMURA HOLDINGS INC holds $202,520,785 across 54 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
318,563 | $23,656,488 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
114,355 | $22,830,975 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,562 | $15,114,383 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
520,947 | $14,591,725 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
968,910 | $14,359,246 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,101 | $11,655,139 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
60,151 | $11,371,546 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
30,942 | $9,188,845 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $297,006 | 83,900 | Call | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||